 Steve Goldstein
Concepts (320)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Potassium Channels, Tandem Pore Domain | 5 | 2017 | 15 | 1.580 |
Why?
| | Potassium Channels | 5 | 2011 | 347 | 1.560 |
Why?
| | Echocardiography | 12 | 2021 | 894 | 1.450 |
Why?
| | Sodium | 3 | 2017 | 344 | 1.370 |
Why?
| | Potassium Channels, Voltage-Gated | 4 | 2015 | 117 | 1.190 |
Why?
| | Practice Guidelines as Topic | 7 | 2019 | 1085 | 1.140 |
Why?
| | Heart Ventricles | 9 | 2021 | 788 | 0.990 |
Why?
| | SUMO-1 Protein | 2 | 2011 | 15 | 0.890 |
Why?
| | Stroke Volume | 6 | 2021 | 430 | 0.870 |
Why?
| | Shal Potassium Channels | 2 | 2010 | 5 | 0.810 |
Why?
| | Neurons | 4 | 2016 | 1612 | 0.800 |
Why?
| | Sumoylation | 2 | 2016 | 17 | 0.790 |
Why?
| | Ventricular Dysfunction | 2 | 2015 | 28 | 0.750 |
Why?
| | Arrhythmias, Cardiac | 2 | 2017 | 208 | 0.660 |
Why?
| | Heart Valve Diseases | 1 | 2017 | 103 | 0.650 |
Why?
| | Aortic Valve Stenosis | 4 | 2019 | 123 | 0.630 |
Why?
| | Aorta | 1 | 2017 | 302 | 0.620 |
Why?
| | Echocardiography, Doppler | 4 | 2019 | 197 | 0.600 |
Why?
| | Aorta, Thoracic | 2 | 2021 | 177 | 0.580 |
Why?
| | Echocardiography, Three-Dimensional | 4 | 2021 | 506 | 0.560 |
Why?
| | Algorithms | 5 | 2021 | 1841 | 0.560 |
Why?
| | Aortic Diseases | 1 | 2015 | 107 | 0.550 |
Why?
| | Cricetulus | 5 | 2016 | 126 | 0.520 |
Why?
| | CHO Cells | 5 | 2016 | 198 | 0.510 |
Why?
| | Potassium | 2 | 2011 | 308 | 0.490 |
Why?
| | Myocytes, Cardiac | 2 | 2015 | 249 | 0.470 |
Why?
| | Hypokalemia | 1 | 2011 | 30 | 0.460 |
Why?
| | Ventricular Function, Left | 3 | 2021 | 581 | 0.460 |
Why?
| | Shab Potassium Channels | 1 | 2011 | 29 | 0.460 |
Why?
| | Xenopus laevis | 5 | 2009 | 142 | 0.440 |
Why?
| | Aortic Valve | 3 | 2019 | 208 | 0.430 |
Why?
| | Kv Channel-Interacting Proteins | 1 | 2010 | 8 | 0.430 |
Why?
| | Image Enhancement | 2 | 2017 | 585 | 0.430 |
Why?
| | Kv1.3 Potassium Channel | 1 | 2009 | 14 | 0.420 |
Why?
| | Societies, Medical | 7 | 2017 | 570 | 0.420 |
Why?
| | Models, Molecular | 3 | 2009 | 1310 | 0.410 |
Why?
| | Scorpion Venoms | 1 | 2009 | 25 | 0.410 |
Why?
| | Neurotoxins | 1 | 2009 | 55 | 0.410 |
Why?
| | Mitral Valve Stenosis | 1 | 2010 | 42 | 0.410 |
Why?
| | Potassium Channel Blockers | 1 | 2009 | 64 | 0.400 |
Why?
| | Rats | 6 | 2016 | 4349 | 0.400 |
Why?
| | Humans | 42 | 2021 | 83061 | 0.390 |
Why?
| | Biopolymers | 1 | 2009 | 25 | 0.390 |
Why?
| | Protein Multimerization | 1 | 2010 | 179 | 0.380 |
Why?
| | Large-Conductance Calcium-Activated Potassium Channels | 1 | 2008 | 12 | 0.380 |
Why?
| | Cell Membrane | 3 | 2010 | 700 | 0.370 |
Why?
| | Models, Chemical | 1 | 2009 | 190 | 0.370 |
Why?
| | Peptides | 2 | 2009 | 638 | 0.370 |
Why?
| | Catheterization | 1 | 2010 | 255 | 0.370 |
Why?
| | Protein Subunits | 1 | 2008 | 119 | 0.360 |
Why?
| | Peptide Hydrolases | 1 | 2008 | 101 | 0.360 |
Why?
| | Multiprotein Complexes | 1 | 2008 | 92 | 0.350 |
Why?
| | Membrane Potentials | 5 | 2015 | 484 | 0.350 |
Why?
| | Hippocampus | 1 | 2011 | 461 | 0.340 |
Why?
| | Animals | 16 | 2016 | 26934 | 0.340 |
Why?
| | Oocytes | 4 | 2009 | 228 | 0.330 |
Why?
| | Cricetinae | 4 | 2015 | 576 | 0.320 |
Why?
| | Protein Biosynthesis | 1 | 2008 | 379 | 0.310 |
Why?
| | Sudden Infant Death | 1 | 2006 | 27 | 0.310 |
Why?
| | Ventricular Dysfunction, Left | 3 | 2019 | 296 | 0.310 |
Why?
| | Small Ubiquitin-Related Modifier Proteins | 1 | 2005 | 12 | 0.300 |
Why?
| | Ion Channel Gating | 2 | 2006 | 335 | 0.300 |
Why?
| | Muscle Proteins | 1 | 2006 | 137 | 0.290 |
Why?
| | Sodium Channels | 1 | 2006 | 130 | 0.290 |
Why?
| | Europe | 5 | 2017 | 311 | 0.290 |
Why?
| | Molecular Sequence Data | 5 | 2011 | 3191 | 0.280 |
Why?
| | Amino Acid Sequence | 4 | 2009 | 2174 | 0.280 |
Why?
| | Drosophila Proteins | 1 | 2009 | 484 | 0.280 |
Why?
| | Nerve Tissue Proteins | 1 | 2008 | 528 | 0.280 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2010 | 672 | 0.280 |
Why?
| | Uterine Hemorrhage | 1 | 2004 | 18 | 0.280 |
Why?
| | Ventricular Dysfunction, Right | 2 | 2016 | 133 | 0.270 |
Why?
| | COS Cells | 3 | 2010 | 170 | 0.270 |
Why?
| | Heart Valve Prosthesis Implantation | 2 | 2017 | 155 | 0.260 |
Why?
| | Female | 22 | 2021 | 44693 | 0.250 |
Why?
| | Kidney | 1 | 2008 | 1232 | 0.230 |
Why?
| | Nursing Staff, Hospital | 1 | 2021 | 46 | 0.220 |
Why?
| | Protein Conformation | 3 | 2009 | 891 | 0.220 |
Why?
| | Point-of-Care Systems | 1 | 2021 | 133 | 0.210 |
Why?
| | Aortic Aneurysm, Thoracic | 1 | 2021 | 80 | 0.210 |
Why?
| | Ventricular Pressure | 1 | 2019 | 30 | 0.210 |
Why?
| | Tomography, X-Ray Computed | 3 | 2017 | 2569 | 0.210 |
Why?
| | Ultrasonography, Interventional | 2 | 2010 | 116 | 0.200 |
Why?
| | Static Electricity | 2 | 2009 | 96 | 0.200 |
Why?
| | Sensitivity and Specificity | 6 | 2017 | 2076 | 0.200 |
Why?
| | Heart Valve Prosthesis | 1 | 2019 | 95 | 0.190 |
Why?
| | Male | 16 | 2021 | 41834 | 0.190 |
Why?
| | Cells, Cultured | 4 | 2015 | 2969 | 0.190 |
Why?
| | Membrane Proteins | 1 | 2005 | 1206 | 0.180 |
Why?
| | Brain | 1 | 2008 | 2157 | 0.170 |
Why?
| | African Americans | 1 | 2006 | 1168 | 0.170 |
Why?
| | Ventricular Outflow Obstruction | 1 | 2017 | 21 | 0.170 |
Why?
| | Ions | 1 | 2017 | 73 | 0.170 |
Why?
| | Cardiac Imaging Techniques | 1 | 2017 | 29 | 0.170 |
Why?
| | Electrophysiological Phenomena | 1 | 2016 | 52 | 0.160 |
Why?
| | Heart Diseases | 1 | 2019 | 314 | 0.160 |
Why?
| | Reproducibility of Results | 4 | 2021 | 2666 | 0.150 |
Why?
| | Patch-Clamp Techniques | 2 | 2008 | 454 | 0.150 |
Why?
| | Decision Making, Computer-Assisted | 1 | 2015 | 13 | 0.150 |
Why?
| | Diagnostic Techniques, Cardiovascular | 1 | 2015 | 13 | 0.150 |
Why?
| | Protein Structure, Tertiary | 2 | 2008 | 766 | 0.150 |
Why?
| | Electrophysiology | 2 | 2007 | 440 | 0.150 |
Why?
| | Vaginal Diseases | 1 | 2015 | 26 | 0.150 |
Why?
| | United States | 7 | 2017 | 6293 | 0.150 |
Why?
| | Estrogen Replacement Therapy | 1 | 2015 | 48 | 0.150 |
Why?
| | Menopause | 1 | 2015 | 68 | 0.150 |
Why?
| | Cerebellum | 1 | 2016 | 235 | 0.150 |
Why?
| | Bronchiolitis Obliterans | 1 | 2015 | 45 | 0.140 |
Why?
| | Preoperative Care | 2 | 2017 | 419 | 0.140 |
Why?
| | Echocardiography, Transesophageal | 2 | 2017 | 353 | 0.140 |
Why?
| | DNA Copy Number Variations | 1 | 2015 | 177 | 0.140 |
Why?
| | Cardiology | 1 | 2015 | 123 | 0.140 |
Why?
| | Tamoxifen | 1 | 2015 | 165 | 0.140 |
Why?
| | Testosterone | 1 | 2015 | 284 | 0.130 |
Why?
| | Adult | 8 | 2021 | 25946 | 0.130 |
Why?
| | Atrial Flutter | 1 | 2013 | 46 | 0.130 |
Why?
| | Graft vs Host Disease | 1 | 2015 | 336 | 0.130 |
Why?
| | Protein Binding | 2 | 2009 | 1506 | 0.130 |
Why?
| | Lung Transplantation | 1 | 2015 | 237 | 0.120 |
Why?
| | Transplantation Conditioning | 1 | 2015 | 366 | 0.120 |
Why?
| | Medicago truncatula | 1 | 2011 | 3 | 0.120 |
Why?
| | Rhizobium | 1 | 2011 | 12 | 0.120 |
Why?
| | Dual Specificity Phosphatase 1 | 1 | 2011 | 17 | 0.120 |
Why?
| | Multiple Myeloma | 1 | 2015 | 285 | 0.120 |
Why?
| | Ion Transport | 1 | 2011 | 84 | 0.110 |
Why?
| | Genome, Plant | 1 | 2011 | 73 | 0.110 |
Why?
| | Pericardiocentesis | 1 | 2010 | 2 | 0.110 |
Why?
| | Aged, 80 and over | 6 | 2021 | 6575 | 0.110 |
Why?
| | Heart Failure, Systolic | 1 | 2010 | 7 | 0.110 |
Why?
| | Osteoblasts | 1 | 2011 | 100 | 0.110 |
Why?
| | Action Potentials | 1 | 2015 | 635 | 0.110 |
Why?
| | Pericardial Effusion | 1 | 2010 | 20 | 0.110 |
Why?
| | Blood Volume | 1 | 2010 | 52 | 0.110 |
Why?
| | Cardiomyopathy, Hypertrophic | 1 | 2011 | 43 | 0.110 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2011 | 103 | 0.110 |
Why?
| | Symbiosis | 1 | 2011 | 98 | 0.110 |
Why?
| | Optical Restriction Mapping | 1 | 2010 | 1 | 0.110 |
Why?
| | Cardiomegaly | 1 | 2010 | 110 | 0.110 |
Why?
| | Lysine | 1 | 2011 | 149 | 0.100 |
Why?
| | Parathyroid Hormone | 1 | 2011 | 238 | 0.100 |
Why?
| | Endometrium | 2 | 2015 | 51 | 0.100 |
Why?
| | Cardiac Pacing, Artificial | 1 | 2010 | 107 | 0.100 |
Why?
| | Computer Systems | 1 | 2010 | 82 | 0.100 |
Why?
| | Bone and Bones | 1 | 2011 | 266 | 0.100 |
Why?
| | Peptide Library | 1 | 2009 | 82 | 0.100 |
Why?
| | Electrodes, Implanted | 1 | 2010 | 176 | 0.100 |
Why?
| | Drug Design | 1 | 2009 | 120 | 0.100 |
Why?
| | Catheter Ablation | 1 | 2013 | 346 | 0.100 |
Why?
| | Cardiovascular Surgical Procedures | 1 | 2009 | 13 | 0.100 |
Why?
| | Surface Plasmon Resonance | 1 | 2009 | 48 | 0.100 |
Why?
| | Magnetic Resonance Imaging, Cine | 1 | 2011 | 185 | 0.100 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2009 | 179 | 0.090 |
Why?
| | Protein Engineering | 1 | 2009 | 139 | 0.090 |
Why?
| | Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2008 | 5 | 0.090 |
Why?
| | Ligands | 1 | 2009 | 425 | 0.090 |
Why?
| | Permeability | 1 | 2008 | 140 | 0.090 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2015 | 811 | 0.090 |
Why?
| | Cell Line | 3 | 2011 | 2614 | 0.090 |
Why?
| | Mass Screening | 1 | 2013 | 622 | 0.090 |
Why?
| | Protein Structure, Quaternary | 1 | 2008 | 107 | 0.090 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2009 | 430 | 0.090 |
Why?
| | Cardiovascular Diseases | 1 | 2015 | 812 | 0.090 |
Why?
| | Muscles | 1 | 2008 | 196 | 0.090 |
Why?
| | Surgery, Computer-Assisted | 1 | 2009 | 107 | 0.090 |
Why?
| | Asparagine | 1 | 2007 | 33 | 0.090 |
Why?
| | Cell Survival | 1 | 2010 | 1012 | 0.090 |
Why?
| | Molecular Conformation | 1 | 2007 | 99 | 0.090 |
Why?
| | Biophysical Phenomena | 1 | 2007 | 123 | 0.080 |
Why?
| | Recombinant Proteins | 1 | 2009 | 1063 | 0.080 |
Why?
| | Crystallography, X-Ray | 1 | 2009 | 497 | 0.080 |
Why?
| | Prospective Studies | 3 | 2021 | 4067 | 0.080 |
Why?
| | Biophysics | 1 | 2007 | 156 | 0.080 |
Why?
| | Rabbits | 1 | 2008 | 716 | 0.080 |
Why?
| | Tryptophan | 1 | 2007 | 88 | 0.080 |
Why?
| | Emergency Service, Hospital | 1 | 2010 | 432 | 0.080 |
Why?
| | Mexiletine | 1 | 2006 | 3 | 0.080 |
Why?
| | Binding Sites | 1 | 2009 | 1122 | 0.080 |
Why?
| | Protein Structure, Secondary | 1 | 2007 | 333 | 0.080 |
Why?
| | Transfection | 1 | 2008 | 943 | 0.080 |
Why?
| | Diastole | 2 | 2019 | 149 | 0.080 |
Why?
| | Cytokines | 1 | 2009 | 748 | 0.080 |
Why?
| | Anti-Arrhythmia Agents | 1 | 2006 | 68 | 0.080 |
Why?
| | Xenopus Proteins | 1 | 2005 | 36 | 0.080 |
Why?
| | Two-Hybrid System Techniques | 1 | 2005 | 52 | 0.080 |
Why?
| | Aged | 6 | 2021 | 18478 | 0.070 |
Why?
| | Metacarpus | 1 | 2004 | 3 | 0.070 |
Why?
| | Genome, Human | 1 | 2010 | 752 | 0.070 |
Why?
| | Cysteine Endopeptidases | 1 | 2005 | 91 | 0.070 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2005 | 554 | 0.070 |
Why?
| | External Fixators | 1 | 2004 | 18 | 0.070 |
Why?
| | Structure-Activity Relationship | 1 | 2005 | 407 | 0.070 |
Why?
| | Endopeptidases | 1 | 2005 | 116 | 0.070 |
Why?
| | Lipids | 1 | 2007 | 387 | 0.070 |
Why?
| | Prognosis | 3 | 2019 | 3698 | 0.070 |
Why?
| | Computer Simulation | 1 | 2009 | 1058 | 0.070 |
Why?
| | Environment | 1 | 2006 | 219 | 0.070 |
Why?
| | Menorrhagia | 1 | 2004 | 11 | 0.070 |
Why?
| | Premenopause | 1 | 2004 | 55 | 0.070 |
Why?
| | Terminology as Topic | 1 | 2005 | 219 | 0.070 |
Why?
| | Biological Evolution | 1 | 2011 | 900 | 0.070 |
Why?
| | Fractures, Bone | 1 | 2004 | 114 | 0.070 |
Why?
| | Mice | 3 | 2015 | 11116 | 0.060 |
Why?
| | T-Lymphocytes | 1 | 2009 | 1287 | 0.060 |
Why?
| | Severity of Illness Index | 2 | 2019 | 1776 | 0.060 |
Why?
| | Predictive Value of Tests | 2 | 2019 | 1752 | 0.060 |
Why?
| | Middle Aged | 5 | 2021 | 25577 | 0.060 |
Why?
| | Polymorphism, Genetic | 1 | 2006 | 821 | 0.060 |
Why?
| | Inservice Training | 1 | 2021 | 36 | 0.060 |
Why?
| | Ultrasonography | 1 | 2004 | 693 | 0.060 |
Why?
| | Case-Control Studies | 1 | 2006 | 1825 | 0.060 |
Why?
| | Heart Atria | 2 | 2013 | 248 | 0.050 |
Why?
| | District of Columbia | 1 | 2019 | 24 | 0.050 |
Why?
| | Biopsy | 1 | 2004 | 1178 | 0.050 |
Why?
| | Preoperative Period | 1 | 2019 | 88 | 0.050 |
Why?
| | Artificial Intelligence | 1 | 2021 | 208 | 0.050 |
Why?
| | Infant | 1 | 2006 | 3085 | 0.050 |
Why?
| | Blood Vessel Prosthesis | 1 | 2021 | 230 | 0.050 |
Why?
| | Cohort Studies | 1 | 2006 | 2704 | 0.050 |
Why?
| | Retrospective Studies | 3 | 2019 | 7598 | 0.050 |
Why?
| | Treatment Outcome | 3 | 2017 | 7885 | 0.050 |
Why?
| | Observer Variation | 1 | 2019 | 621 | 0.040 |
Why?
| | Genetic Predisposition to Disease | 1 | 2006 | 2215 | 0.040 |
Why?
| | Mice, Inbred C57BL | 2 | 2015 | 3175 | 0.040 |
Why?
| | Orchiectomy | 1 | 2015 | 64 | 0.040 |
Why?
| | Mortality | 1 | 2016 | 148 | 0.040 |
Why?
| | Consensus | 1 | 2017 | 291 | 0.040 |
Why?
| | Loss of Heterozygosity | 1 | 2015 | 87 | 0.040 |
Why?
| | Endometrial Hyperplasia | 1 | 2015 | 7 | 0.040 |
Why?
| | Monitoring, Physiologic | 1 | 2017 | 284 | 0.040 |
Why?
| | Vulva | 1 | 2015 | 21 | 0.040 |
Why?
| | Tricuspid Valve Insufficiency | 1 | 2016 | 99 | 0.040 |
Why?
| | Myeloablative Agonists | 1 | 2015 | 34 | 0.040 |
Why?
| | Ventricular Function, Right | 1 | 2016 | 146 | 0.040 |
Why?
| | Atrophy | 1 | 2015 | 66 | 0.040 |
Why?
| | Dyspareunia | 1 | 2015 | 12 | 0.040 |
Why?
| | Survival Rate | 1 | 2019 | 1918 | 0.040 |
Why?
| | Selective Estrogen Receptor Modulators | 1 | 2015 | 30 | 0.040 |
Why?
| | Unrelated Donors | 1 | 2015 | 49 | 0.040 |
Why?
| | Respiratory Function Tests | 1 | 2015 | 147 | 0.040 |
Why?
| | Siblings | 1 | 2015 | 111 | 0.040 |
Why?
| | Incidence | 1 | 2019 | 1638 | 0.040 |
Why?
| | Congresses as Topic | 1 | 2015 | 121 | 0.040 |
Why?
| | Placebos | 1 | 2015 | 233 | 0.040 |
Why?
| | Postmenopause | 1 | 2015 | 96 | 0.040 |
Why?
| | Vagina | 1 | 2015 | 104 | 0.030 |
Why?
| | Evidence-Based Medicine | 1 | 2017 | 452 | 0.030 |
Why?
| | Gene Deletion | 1 | 2015 | 346 | 0.030 |
Why?
| | Forecasting | 1 | 2015 | 320 | 0.030 |
Why?
| | Mutation | 1 | 2005 | 3852 | 0.030 |
Why?
| | Risk Factors | 2 | 2015 | 5401 | 0.030 |
Why?
| | Endometrial Neoplasms | 1 | 2015 | 173 | 0.030 |
Why?
| | Transplantation, Homologous | 1 | 2015 | 1020 | 0.030 |
Why?
| | Soybeans | 1 | 2011 | 12 | 0.030 |
Why?
| | Synteny | 1 | 2011 | 25 | 0.030 |
Why?
| | Vitis | 1 | 2011 | 18 | 0.030 |
Why?
| | Acid Phosphatase | 1 | 2011 | 37 | 0.030 |
Why?
| | Osteocalcin | 1 | 2011 | 25 | 0.030 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 1 | 2011 | 23 | 0.030 |
Why?
| | Nitrogen Fixation | 1 | 2011 | 46 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2015 | 1011 | 0.030 |
Why?
| | Sex Factors | 1 | 2015 | 1089 | 0.030 |
Why?
| | Mice, 129 Strain | 1 | 2011 | 52 | 0.030 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2011 | 72 | 0.030 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2011 | 79 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2019 | 3875 | 0.030 |
Why?
| | Cyclin D1 | 1 | 2011 | 81 | 0.030 |
Why?
| | Guideline Adherence | 1 | 2013 | 225 | 0.030 |
Why?
| | Venous Pressure | 1 | 2010 | 12 | 0.030 |
Why?
| | X-Ray Microtomography | 1 | 2011 | 77 | 0.030 |
Why?
| | Systole | 1 | 2011 | 142 | 0.030 |
Why?
| | Heart Injuries | 1 | 2010 | 17 | 0.030 |
Why?
| | Thoracic Injuries | 1 | 2010 | 29 | 0.030 |
Why?
| | Thrombosis | 1 | 2013 | 272 | 0.030 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 2011 | 96 | 0.030 |
Why?
| | Hydatidiform Mole | 1 | 2010 | 6 | 0.030 |
Why?
| | Chest Pain | 1 | 2010 | 42 | 0.030 |
Why?
| | Survival Analysis | 1 | 2015 | 1585 | 0.030 |
Why?
| | Patient Safety | 1 | 2013 | 212 | 0.030 |
Why?
| | Isoenzymes | 1 | 2011 | 276 | 0.030 |
Why?
| | Dyspnea | 1 | 2010 | 80 | 0.030 |
Why?
| | Age Factors | 1 | 2015 | 1913 | 0.030 |
Why?
| | Hypotension | 1 | 2010 | 75 | 0.030 |
Why?
| | Radiology Information Systems | 1 | 2010 | 78 | 0.030 |
Why?
| | Shock, Cardiogenic | 1 | 2010 | 72 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2015 | 1899 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2011 | 562 | 0.030 |
Why?
| | Anticoagulants | 1 | 2013 | 396 | 0.030 |
Why?
| | Blotting, Western | 1 | 2011 | 831 | 0.020 |
Why?
| | Neuropeptide Y | 1 | 1989 | 32 | 0.020 |
Why?
| | Decision Making | 1 | 2015 | 617 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 923 | 0.020 |
Why?
| | Vasoconstrictor Agents | 1 | 1989 | 53 | 0.020 |
Why?
| | DNA | 1 | 2015 | 1300 | 0.020 |
Why?
| | Lung | 1 | 2015 | 1058 | 0.020 |
Why?
| | Young Adult | 1 | 2021 | 5958 | 0.020 |
Why?
| | Lymphocytes | 1 | 2010 | 475 | 0.020 |
Why?
| | Heart Arrest | 1 | 2010 | 262 | 0.020 |
Why?
| | Coronary Vessels | 1 | 1989 | 187 | 0.020 |
Why?
| | Coronary Disease | 1 | 1989 | 308 | 0.020 |
Why?
| | Uterine Neoplasms | 1 | 2010 | 180 | 0.020 |
Why?
| | Education, Medical, Graduate | 1 | 2010 | 331 | 0.020 |
Why?
| | Gene Expression | 1 | 2011 | 1331 | 0.020 |
Why?
| | Curriculum | 1 | 2010 | 469 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2015 | 2328 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2011 | 1954 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2010 | 1604 | 0.020 |
Why?
| | Polymethyl Methacrylate | 1 | 2004 | 13 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2011 | 1474 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2010 | 2422 | 0.020 |
Why?
| | Equipment Design | 1 | 2004 | 421 | 0.020 |
Why?
| | Pregnancy | 1 | 2010 | 2807 | 0.020 |
Why?
| | Genetic Variation | 1 | 2010 | 1357 | 0.020 |
Why?
| | Genome-Wide Association Study | 1 | 2010 | 1522 | 0.020 |
Why?
| | Internship and Residency | 1 | 2010 | 897 | 0.010 |
Why?
| | Adolescent | 1 | 2015 | 9119 | 0.010 |
Why?
| | Injections, Intra-Arterial | 1 | 1989 | 40 | 0.010 |
Why?
| | Vascular Resistance | 1 | 1989 | 106 | 0.010 |
Why?
| | Coronary Circulation | 1 | 1989 | 135 | 0.010 |
Why?
| | Dogs | 1 | 1989 | 794 | 0.010 |
Why?
| | Heart Rate | 1 | 1989 | 559 | 0.000 |
Why?
|
|
Goldstein's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Physical Neighbors People whose addresses are nearby this person. _
|